Tarsus Pharmaceuticals Inc (TARS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 156,199 | 168,149 | 86,349 | 0 | 0 |
| Receivables | 25,247 | 20 | 1 | 0 | 0 |
| Other current assets | 7,199 | 0 | 0 | 0 | 0 |
| TOTAL | $191,451 | $170,655 | $89,072 | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 589 | 548 | 604 | N/A | N/A |
| Other Non-Current Assets | 1,914 | 769 | 2,509 | 0 | 0 |
| TOTAL | $2,503 | $1,317 | $3,113 | $N/A | $N/A |
| Total Assets | $193,954 | $171,972 | $92,185 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,433 | 4,347 | 5,624 | 0 | 0 |
| TOTAL | $10,118 | $5,387 | $6,144 | $0 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 604 | 605 | 711 | 0 | 0 |
| TOTAL | $604 | $605 | $711 | $N/A | $N/A |
| Total Liabilities | $10,722 | $5,992 | $6,855 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 20,524 | 20,503 | 20,320 | N/A | N/A |
| Common Shares | 4 | 4 | 2 | 0 | 0 |
| Retained earnings | -22,469 | -32,845 | -21,379 | 0 | 0 |
| TOTAL | $183,232 | $165,980 | $85,330 | $0 | $0 |
| Total Liabilities And Equity | $193,954 | $171,972 | $92,185 | $0 | $0 |